Boobis A R, Hampden C E, Murray S, Beaune P, Davies D S
Br J Clin Pharmacol. 1985 Jun;19(6):721-9. doi: 10.1111/j.1365-2125.1985.tb02706.x.
Twenty-eight samples of human liver have been characterised for cytochrome P-450 content, aldrin epoxidase, debrisoquine 4-hydroxylase and bufuralol 1'-hydroxylase activities. Evidence is presented here and elsewhere that bufuralol 1'-hydroxylase and debrisoquine 4-hydroxylase are activities catalysed by the same form of cytochrome P-450 in man, and that this form is different from that catalysing the epoxidation of aldrin. Attempts to phenotype liver samples in vitro, in the absence of any metabolic data in vivo for debrisoquine 4-hydroxylation status, met with limited success. A combination of enzyme assays will most probably be required in any such phenotyping of human liver samples.
对28份人类肝脏样本进行了细胞色素P - 450含量、艾氏剂环氧化酶、异喹胍4 - 羟化酶和丁呋洛尔1'-羟化酶活性的表征。本文及其他地方均有证据表明,丁呋洛尔1'-羟化酶和异喹胍4 - 羟化酶是由人类细胞色素P - 450的同一种形式催化的活性,并且这种形式与催化艾氏剂环氧化的形式不同。在缺乏异喹胍4 - 羟化状态的任何体内代谢数据的情况下,试图在体外对肝脏样本进行表型分析,取得的成功有限。在对人类肝脏样本进行任何此类表型分析时,很可能需要结合多种酶测定法。